Rivastigmine Film, Extended Release shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Sep 18, 2026 · last update Sep 18, 2026
Manufacturers: Mylan Pharmaceuticals Inc., a Viatris Company
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Rivastigmine, Film, Extended Release, 4.6 mg/24 h (NDC 0378-9070-93) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued | — | Discontinuation of the manufacture of the drug. | Posted Sep 18, 2026 Updated Sep 18, 2026 Discontinued Sep 18, 2026 |